JD Health International revenue and financials
$35.34Change from previous close: +0.57%Absolute change: +$0.20
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 81,587 | 71,275 | 64,288 | 61,277 | — |
| Current assets | 56,349 | 58,460 | 47,850 | 56,447 | — |
| Cash and equivalents | 31,785 | 22,629 | 15,037 | 18,718 | — |
| Short-term investments | 16,366 | 28,607 | 26,184 | 28,954 | — |
| Inventory | 6,858 | 5,843 | 5,085 | 5,996 | — |
| Net property, plant and equipment | 1,230 | 803 | 741 | 705 | — |
| Other intangible assets | 1,933 | 2,095 | 2,182 | 2,268 | — |
| Long-term investments | 200 | 264 | 348 | 418 | — |
| Current liabilities | 20,741 | 15,521 | 14,585 | 16,356 | — |
| Accounts payable | 13,210 | 10,423 | 9,660 | 10,526 | — |
| Total debt | 636 | 258 | 215 | 199 | — |
| Total liabilities | 21,513 | 16,034 | 14,918 | 16,493 | — |
| Total equity (incl. minority) | 60,073 | 55,241 | 49,370 | 44,785 | — |
| Retained earnings | -7,971 | -13,224 | -17,336 | -19,382 | — |
| Minority interest | 1.4 | 9.7 | 14.5 | 4.3 | — |